Jean-Michel Scherrmann

InstitutionUniversity of Paris
AddressParis
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 2 publications in January 2021
    All Publications
    Bar chart showing 195 publications over 27 distinct years, with a maximum of 15 publications in 1995
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mégarbane B, Bourasset F, Scherrmann JM. Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses. J Gen Intern Med. 2021 09; 36(9):2731-2738. PMID: 34131877.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Mégarbane B, Bourasset F, Scherrmann JM. Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?-a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools. J Gen Intern Med. 2021 03; 36(3):746-752. PMID: 33442818.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    3. Mégarbane B, Scherrmann JM. Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. J Antimicrob Chemother. 2021 01 01; 76(1):276-277. PMID: 32766679.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    4. Scherrmann JM. Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy. Clin Pharmacol Ther. 2021 05; 109(5):1180. PMID: 32804426.
      Citations: 1     Fields:    Translation:HumansCells
    5. Scherrmann JM. Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy. AAPS J. 2020 06 12; 22(4):86. PMID: 32533263.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    6. Mégarbane B, Scherrmann JM. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes? J Clin Pharmacol. 2020 07; 60(7):808-814. PMID: 32434282.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health